1. Home
  2. SYPR vs ANVS Comparison

SYPR vs ANVS Comparison

Compare SYPR & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sypris Solutions Inc.

SYPR

Sypris Solutions Inc.

HOLD

Current Price

$3.59

Market Cap

61.0M

Sector

Industrials

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.92

Market Cap

60.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYPR
ANVS
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.0M
60.1M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
SYPR
ANVS
Price
$3.59
$1.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
96.4K
1.3M
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.39
EPS
N/A
N/A
Revenue
$82,294,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$1.36
52 Week High
$4.74
$5.50

Technical Indicators

Market Signals
Indicator
SYPR
ANVS
Relative Strength Index (RSI) 52.93 44.13
Support Level $1.97 $1.56
Resistance Level $4.03 $2.67
Average True Range (ATR) 0.31 0.14
MACD 0.01 0.03
Stochastic Oscillator 44.59 72.00

Price Performance

Historical Comparison
SYPR
ANVS

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics. The company offers a range of manufacturing, engineering, design, and other technical services. The business activity of the firm is functioned through Sypris Technologies and Sypris Electronics segments. Sypris Technologies segment is engaged in the sales of machined, welded, and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications whereas the Sypris Electronics segment is engaged in the sale of manufacturing services, technical services, and products to customers in the market for aerospace and defense electronics. Sypris derives the revenue from the Technologies segment.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: